secwatch / observer
8-K filed November 2, 2022, 7:59 PM ET ticker POCI CIK 0000867840
other material confidence high sentiment neutral materiality 0.65

Precision Optics completes 1:3 reverse stock split targeting Nasdaq uplisting

PRECISION OPTICS CORPORATION, INC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PRECISION OPTICS CORPORATION, INC.: Filed Articles of Amendment to effect a 1:3 reverse stock split of Common Stock, with effective date set to 11:59 p.m. Eastern Time on November 1, 2022, after prior delays and re-filings (effective 2022-11-01).

Change
charter amendment
Effective
2022-11-01
Exact text from the filing
The Company filed Articles of Amendment with the Secretary of the Commonwealth of Massachusetts on October 24, 2022. Under that filing, the Reverse Stock Split was to become effective after the close of business on Wednesday, October 26, 2022. Due to unanticipated delays in obtaining necessary trading clearances, however, the Company on October 26, 2022 made a further Articles of Amendment filing with the Secretary of the Commonwealth to override the earlier amendment and thus avoid the reverse split taking effect later that day. Having received appropriate indications on October 27, 2022 that the necessary trading clearances would be forthcoming, the Company then set a new effective date of the Reverse Stock Split for 11:59 p.m. Eastern Time on Tuesday, November 1, 2022 (the “Revised Effective Time”) and filed additional Articles of Amendment with the Secretary of the Commonwealth accordingly on October 27, 2022.
View on SEC.gov

27 governance changes filed in the last 30 days. Browse all governance changes →

PRECISION OPTICS CORPORATION, INC. filing history →

Source: SEC EDGAR
accession 0001683168-22-007213
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.